Medtronic PLC  

(Public, NYSE:MDT)   Watch this stock  
Find more results for MDT
87.10
-0.84 (-0.96%)
Jul 22 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 86.25 - 87.83
52 week 55.54 - 89.27
Open 87.83
Vol / Avg. 0.00/5.00M
Mkt cap 121.48B
P/E 35.07
Div/yield 0.43/1.97
EPS 2.48
Shares 1.40B
Beta 0.90
Inst. own 85%
Aug 25, 2016
Q1 2017 Medtronic plc Earnings Release - 9:30AM EDT - Add to calendar
Aug 25, 2016
Q1 2017 Medtronic PLC Earnings Call Add to calendar
Jun 12, 2016
Medtronic Analyst Briefing at American Diabetes Association - Webcast
Jun 7, 2016
Medtronic PLC at Goldman Sachs Global Healthcare Conference
Jun 7, 2016
Medtronic PLC at Jefferies Healthcare Conference
Jun 6, 2016
Medtronic PLC Investor Day - Webcast
May 31, 2016
Q4 2016 Medtronic plc Earnings Release
May 31, 2016
Q4 2016 Medtronic PLC Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q2 (Apr '16) 2016
Net profit margin 14.58% 12.27%
Operating margin 19.89% 18.35%
EBITD margin - 30.57%
Return on average assets 4.37% 3.43%
Return on average equity 8.60% 6.72%
Employees 88,000 -
CDP Score - 80 D

Address

20 On Hatch, Hatch Street Lower
DUBLIN, 2
Ireland
+353-1-4381700 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Medtronic plc (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. Medtronic, Inc. is a subsidiary of the Company.

Officers and directors

Omar Syed Ishrak Chairman of the Board, Chief Executive Officer
Age: 59
Bio & Compensation  - Reuters
Gary L. Ellis Executive Vice President - Global Operations and Information Technology, Director
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Carol A. Surface Chief Human Resource Officer, Senior Vice President
Age: 49
Bio & Compensation  - Reuters
Michael J. Coyle Executive Vice President, Group President - Cardiac and Vascular Group
Age: 52
Bio & Compensation  - Reuters
Hooman C. Hakami Executive Vice President and Group President of the Medtronic Diabetes Group
Age: 45
Bio & Compensation  - Reuters
Bryan C. Hanson Executive Vice President, Group President - Minimally Invasive Therapies Group
Age: 48
Bio & Compensation  - Reuters
Robert ten Hoedt Executive Vice President and President, EMEAC
Age: 54
Bio & Compensation  - Reuters
Bradley E. Lerman Senior Vice President, General Counsel, Corporate secretary
Age: 58
Bio & Compensation  - Reuters
Geoffrey S. Martha Senior Vice President - Strategy and Business Development
Age: 45
Bio & Compensation  - Reuters
Richard H. Anderson Lead Independent Director
Age: 60
Bio & Compensation  - Reuters